<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2182-5173</journal-id>
<journal-title><![CDATA[Revista Portuguesa de Medicina Geral e Familiar]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Port Med Geral Fam]]></abbrev-journal-title>
<issn>2182-5173</issn>
<publisher>
<publisher-name><![CDATA[Associação Portuguesa de Medicina Geral e Familiar]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2182-51732022000200137</article-id>
<article-id pub-id-type="doi">10.32385/rpmgf.v38i2.13337</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[Infeções do trato urinário nos cuidados de saúde primários: estado da arte]]></article-title>
<article-title xml:lang="en"><![CDATA[Urinary tract infection in primary care: state of the art]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Machado]]></surname>
<given-names><![CDATA[Gabriela]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Marinho]]></surname>
<given-names><![CDATA[Ana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Afonso]]></surname>
<given-names><![CDATA[Joana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Freitas]]></surname>
<given-names><![CDATA[Marta]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[Mara]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Coelho]]></surname>
<given-names><![CDATA[Ricardo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,ACeS Almada-Seixal USF São João do Pragal ]]></institution>
<addr-line><![CDATA[Almada ]]></addr-line>
<country>Portugal</country>
</aff>
<pub-date pub-type="pub">
<day>30</day>
<month>04</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>30</day>
<month>04</month>
<year>2022</year>
</pub-date>
<volume>38</volume>
<numero>2</numero>
<fpage>137</fpage>
<lpage>145</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_arttext&amp;pid=S2182-51732022000200137&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_abstract&amp;pid=S2182-51732022000200137&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_pdf&amp;pid=S2182-51732022000200137&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo  Introdução: A infeção do trato urinário (ITU) é a segunda infeção mais frequente da comunidade.  Objetivos: Determinar os micro-organismos responsáveis pelas ITU nos cuidados de saúde primários e o seu perfil de sensibilidade aos antibióticos, bem como avaliar se a abordagem das ITU está a ser feita de acordo com as recomendações da DGS.  Métodos: Estudo observacional e retrospetivo em quatro USF de Almada. Foram incluídos os utentes de idade igual ou superior a 18 anos, a quem foram codificados os problemas do ICPC-2 (U71-Cistite/Infeção Urinária Outra e U70-Pielonefrite/Pielite), de julho a dezembro de 2019. A recolha da informação foi feita através do programa informático SClínico e da plataforma MIM@UF. As variáveis estudadas foram: sexo, idade, tipo de ITU, pedido de urocultura, antibioterapia empírica, resultado da urocultura e teste de sensibilidade aos antimicrobianos.  Resultados: Das 963 ITU, 88,3% ocorreram em mulheres, principalmente entre os 68 e 77 anos (18,9%). O tipo de ITU mais prevalente foi a cistite não complicada na mulher não grávida (56,3%). A antibioterapia empírica foi prescrita em 86,7% dos casos, sendo a fosfomicina o antibiótico mais utilizado (58,6%). Foram feitos 405 pedidos de urocultura, na sua maioria com resultado positivo. O micro-organismo mais frequentemente identificado foi a E. coli (66,4%), sendo o mais prevalente em todos os grupos etários e nos diferentes tipos de ITU, e sensível em 63,7% dos casos à fosfomicina. Na análise global das diferentes unidades verificou-se que a urocultura foi pedida em concordância com a norma da DGS em 70,4% dos casos e que a antibioterapia empírica esteve de acordo com a DGS em 63% dos casos.  Conclusões: Neste estudo conclui-se que as ITU são mais frequentes nas mulheres entre os 68 e 77 anos. O micro-organismo mais prevalente é a E.coli, apresentando uma sensibilidade significativa à fosfomicina e à nitrofurantoína.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction: Urinary tract infection (UTI) is the second most prevalent infection in the community.  Aims:  To determine the microorganisms responsible for UTI in Primary Health Care and their profile of sensitivity to antibiotics, as well as to evaluate if the approach of the UTI is concordant with the National Health Authority&#8217;s recommendations.  Methods:  Observational and retrospective study in four primary health care centers in Almada. Patients aged 18 years or older, whose appointments were coded with ICPC-2&#8217;s problems (U71-Cystitis/Urinary Infection Other and U70-Pyelonephritis/Pyelitis) between July and December 2019 were included. The SClínico software and the MIM@UF platform were chosen to collect data. The variables studied were: sex, age, type of UTI, urine culture request, empirical antibiotics, the result of urine culture, and antimicrobial sensitivity test.  Results:  Of the 963 UTIs, 88.3% occurred in women, mainly between 68 and 77 years old (18.9%). The most prevalent type of UTI was uncomplicated cystitis in non-pregnant women (56.3%). Empirical antibiotic therapy was prescribed in 86.7% of the cases, with fosfomycin being the most used one (58.6%). Four hundred and five urine culture requests were made, most of them with a positive result. E. coli was the most frequently identified microorganism (66.4%), being the most prevalent in all age groups and in the different types of UTI. It was sensitive to fosfomycin in 63.7% of cases. In the global analysis of the different units, it was found that urine culture was in accordance with the national recommendation in 70.4% of the cases and that empirical antibiotics were in accordance in 63% of the UTI cases.  Conclusions:  UTIs in the community are more frequent in women between 68 and 77 years old. The most prevalent bacterial microorganism is E.coli, with significant sensitivity to fosfomycin and nitrofurantoin.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[Infeção do trato urinário]]></kwd>
<kwd lng="pt"><![CDATA[Antibióticos]]></kwd>
<kwd lng="pt"><![CDATA[Resistência antimicrobiana]]></kwd>
<kwd lng="en"><![CDATA[Urinary tract infection]]></kwd>
<kwd lng="en"><![CDATA[Antibiotics]]></kwd>
<kwd lng="en"><![CDATA[Antibiotic resistance]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tavares]]></surname>
<given-names><![CDATA[IV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Perfil de prescrição de antimicrobianos para as infecções do tracto urinário nos cuidados de saúde primários]]></article-title>
<source><![CDATA[Rev Port Med Geral Fam]]></source>
<year>2014</year>
<volume>30</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>85-100</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sun]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reducing antibiotic prescribing in primary care in England from 2014 to 2017: population-based cohort study]]></article-title>
<source><![CDATA[BMJ Open]]></source>
<year>2019</year>
<volume>9</volume>
<numero>7</numero>
<issue>7</issue>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saha]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
<name>
<surname><![CDATA[Hawes]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Mazza]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Improving antibiotic prescribing by general practitioners a protocol for a systematic review of interventions involving pharmacists]]></article-title>
<source><![CDATA[BMJ Open]]></source>
<year>2018</year>
<volume>8</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<collab>Infarmed</collab>
<source><![CDATA[Recomendações sobre antibioterapia: orientações da Comissão Nacional de Farmácia e Terapêutica, nº 7, setembro 2018]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Lisboa ]]></publisher-loc>
<publisher-name><![CDATA[Infarmed]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Correia]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Etiologia das infecções do tracto urinário e sua susceptibilidade aos antimicrobianos]]></article-title>
<source><![CDATA[Acta Med Port]]></source>
<year>2007</year>
<volume>20</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>543-9</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<collab>European Centre for Disease Prevention and Control</collab>
<source><![CDATA[Surveillance of antimicrobial resistance in Europe 2018]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Stockholm ]]></publisher-loc>
<publisher-name><![CDATA[ECDC]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martins]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Avaliação do perfil de susceptibilidade aos antimicrobianos de microrganismos isolados em urinas na Região do Vale do Sousa e Tâmega]]></article-title>
<source><![CDATA[Acta Med Port]]></source>
<year>2010</year>
<volume>23</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>641-6</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<collab>Direção-Geral da Saúde</collab>
<source><![CDATA[Terapêutica de infeções do aparelho urinário (comunidade): norma nº 015/2011, de 30/08/2011]]></source>
<year>2011</year>
<publisher-loc><![CDATA[Lisboa ]]></publisher-loc>
<publisher-name><![CDATA[DGS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<collab>European Centre for Disease Prevention and Control</collab>
<source><![CDATA[Summary of the latest data on antibiotic consumption in the European Union]]></source>
<year>2017</year>
<publisher-loc><![CDATA[Stockholm ]]></publisher-loc>
<publisher-name><![CDATA[ECDC]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
